Feedback / Questions
pemvidutide (ALT-801) - Altimmune
https://www.biospace.com/article/releases/altimmune-announces-positive-topline-results-from-momentum-48-week-phase-2-obesity-trial-of-pemvidutide/
Nov 30, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next